Primary Vitreoretinal Lymphoma: A Report from an International Primary Central Nervous System Lymphoma Collaborative Group Symposium
Year: 2011
Type: review
Abstract: Primary vitreoretinal lymphoma (PVRL), also known as primary intraocular lymphoma, is a rare malignancy typically classified as a diffuse large B-cell lymphoma and most frequently develops in elderly populations. PVRL commonly masquerades as posterior uveitis and has a unique tropism for the retina and central nervous system (CNS). Over 15% of primary CNS lymphoma patients develop intraocular lymphoma, usually occurring in the retina and/or vitreous. Conversely, 65%-90% of PVRL patients develop CNS lymphoma. Consequently, PVRL is often fatal because of ultimate CNS association. Current PVRL animal models are limited and require further development. Typical clinical findings include vitreous cellular infiltration (lymphoma and inflammatory cells) and subretinal tumor infiltration as determined using dilated fundoscopy, fluorescent angiography, and optical coherent tomography. Currently, PVRL is most often diagnosed using both histology to identify lymphoma cells in the vitreous or retina and immunohistochemistry to indicate monoclonality. Additional adjuncts in diagnosing PVRL exist, including elevation of interleukin-10 levels in ocular fluids and detection of Ig(H) or T-cell receptor gene rearrangements in malignant cells. The optimal therapy for PVRL is not defined and requires the combined effort of oncologists and ophthalmologists. PVRL is sensitive to radiation therapy and exhibits high responsiveness to intravitreal methotrexate or rituximab. Although systemic chemotherapy alone can result in high response rates in patients with PVRL, there is a high relapse rate. Because of the disease rarity, international, multicenter, collaborative efforts are required to better understand the biology and pathogenesis of PVRL as well as to define both diagnostic markers and optimal therapies.
Source: The Oncologist
Institutions: National Institutes of Health, National Eye Institute, University of California, San Francisco, Royal Liverpool University Hospital, Liverpool University Hospitals NHS Foundation Trust, University of Miami, Washington University in St. Louis, Mayo Clinic, Pitié-Salpêtrière Hospital, Institut Curie, Oregon Health & Science University, Harvard University, Massachusetts General Hospital
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Keywords: primary vitreoretinal lymphoma, primary intraocular lymphoma, primary central nervous system lymphoma, diffuse large B-cell lymphoma, immunohistochemistry, IL-10, T-cell receptor gene rearrangement, intravitreal methotrexate, rituximab, radiotherapy, systemic chemotherapy, relapse, animal models
Open Access status: bronze
OpenAlex ID: W1983979831
